ALA arovella therapeutics limited

Yesterday's announcement of the safe progression of the lead-in...

  1. 2,339 Posts.
    lightbulb Created with Sketch. 347
    Yesterday's announcement of the safe progression of the lead-in study using only the CD19 expressing oncolytic virus is also good news for Arovella (if the ALA-101 / onCARlytics in vivo trial is successful).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.3¢
Change
-0.001(1.06%)
Mkt cap ! $110.9M
Open High Low Value Volume
9.2¢ 9.5¢ 9.0¢ $123.4K 1.344M

Buyers (Bids)

No. Vol. Price($)
1 6300 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 118372 2
View Market Depth
Last trade - 15.04pm 13/08/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.